Viridian Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2016 | 26.7% | -488.6% | -496.8% |
| FY2017 | — | -662.8% | -662.3% |
| FY2018 | — | -394.5% | -390.0% |
| FY2019 | — | -941.0% | -938.6% |
| FY2020 | — | -10,512.4% | -10,544.3% |
| FY2021 | — | -2,690.8% | -2,680.2% |
| FY2022 | — | -7,579.2% | -7,329.2% |
| FY2023 | — | -81,035.0% | -75,711.5% |
| FY2024 | — | -99,018.2% | -89,387.1% |
| FY2025 | — | -512.9% | -483.6% |